Introduction
Wireless video capsule-endoscopy (VCE) is a valuable method for evaluating the gastrointestinal tract, which was first approved by the FDA in 2000. 1 The PillCam SB (Given Imaging, Duluth, Georgia) is the sole approved VCE available in the United States, measuring 1.1 cm × 2.6 cm and consists of a plastic capsule encasing a metal oxide silicon chip camera, lens, six light-emitting diodes (LED), two silver dioxide battery sources, and an ultra-high frequency radio-transmitter. Along with double-balloon endoscopy (DBE), capsule endoscopy allows for direct visualization of small intestinal lesions and monitoring of chronic disease. 1 Current applications and contraindications to the use of capsule endoscopy are shown in Table 1 . In particular, potential benefits of capsule endoscopy in the setting of Crohn's disease are to diagnose lesions absent on initial imaging, monitor the activity of disease, identify post-operative exacerbations, and screening for neoplastic or infectious lesions in established disease. 2 Although the VCE is a relatively small device, capsule retention is a significant complication that is often under-recognized. Capsule retention is more likely to occur in patients with established contraindications shown in Table 1 . In particular, Crohn's disease has been shown to increase risk of capsule retention more than any other established risk factor with an incidence up to 7.3%. 3, 4 Although spontaneous passage of a retained capsule has been described after a brief period, the associated incidence of small bowel obstruction requiring eventual intervention for capsule extraction via double-balloon endoscopy or surgical resection has been shown to be approximately 7.3%. 2, 3 In the setting of retained VCE, the most significant complication that must be evaluated for is intestinal perforation. While the morbidity and mortality for intestinal perforation secondary to a retained VCE is significant, to date there have only been three cases reported since the original FDA approval. [5] [6] [7] In each reported case active Crohn's disease was noted at the site of the capsule-associated intestinal perforation, suggesting thinning and friability as a predisposing pathophysiologic event to the perforation. Despite multiple components, to date there is only a single case report of mechanical failure in the device allowing capsule fragmentation. 8 If capsule fragmentation occurs however, the risk for intestinal perforation would likely significantly increase risk of intestinal perforation. We report a single case of a patient with a retained capsule endoscopy for three years with evidence of multicentric small bowel obstruction secondary to capsule fragments located at strictured small intestine.
Presentation of case
A 39 year old male presented to the Emergency Department with an acute episode of sharp abdominal pain, nausea, and bilious emesis for approximately 48 h. He reportedly had multiple similar episodes in the past which had been determined to be partial small bowel obstructions. CT of the abdomen demonstrated intestinal wall thickening from the mid-jejunum to the terminal ileum with a visible stricture in the distal jejunum, as shown in Fig. 1 . Dilated small bowel loops were located proximal to a previous enteroenterostomy where a metallic object was located. An additional metallic object was present within the distal jejunum. A diagnosis of partial small bowel obstruction was made based on clinical and radiologic imaging, which appeared to be secondary to intra-luminal foreign bodies located at a jejunal stricture.
The patient had been previously diagnosed with Crohn's disease by colonoscopy at approximately age 18 and had required two previous surgeries for enterectomy of stricture disease. He had resisted continued disease-modifying medications and continued to have episodes of abdominal pain. Approximately 3 years prior to the presenting episode he had undergone a VCE procedure to evaluate activity of his Crohn's disease by a local gastroenterologist. The patient reported that he was unable to pass the capsule and due to non-compliance with follow-up did not present for further evaluation. He denied noticing passage of the capsule between its placement and the presenting episode. He subsequently had developed episodes of sharp abdominal pain similar to his previous episodes of small bowel obstructions which resolved after several days of self-management.
The patient underwent urgent exploratory laparotomy for structuring Crohn's disease with small-bowel obstruction and retained capsule. At exploration he was found to have a previous loop enteroenterostomy at the mid-jejunum with a stricture located at the anastomosis and a capsule fragment located at the stricture proximally as shown in Fig. 2 . An additional capsule fragment was located distally at an additional stricture point within the proximal ileum. The capsule fragments were removed through enterostomy and resection of the strictured jejunum was performed, with subsequent side-side enteroenterostomy. Pathology of the resected strictured jejunum demonstrated focal scarring without active disease foci. Post-operatively the patient was monitored and demonstrated return of oral feeding tolerance and complete resolution of pain. He was evaluated for incidental findings of liver masses on admission imaging and diagnosed with multiple small hepatic hemangiomas. He was seen in outpatient follow-up and has remained symptom free.
Discussion
Wireless VCE represents an important evaluation method for the jejunum and ileum due to the significant length, generally inaccessibility to traditional endoscopic methods, and low sensitivity and specificity of traditional imaging modalities. The American Society for Gastrointestinal Endoscopy (ASGE) developed and published recommended indications and contraindications for VCE in 2006, Table 1 . 1 An important contraindication included in these guidelines is the presence of a stricture or small bowel obstruction. A previous study by Cheon et al. demonstrated that diagnosed or suspected Crohn's disease is associated with a statistically significant risk of capsule retention compared to all other causes of retained VCE capsules. 4 There have been reported successes in spontaneous passage of retained VCE capsules in patients with Crohn's disease. 9, 10 In the presence of suspected active Crohn's disease with absence of findings concerning for intestinal perforation or non-resolving small bowel obstruction a reasonable approach may be treatment with immunosuppressant therapy. 10 However, without clear evidence of active Crohn's disease, clinical findings concerning for bowel perforation, or failure to progress on immunosuppressant therapy the evidence clearly supports prompt surgical intervention to prevent complications associated with free intestinal perforation. 5, 6, 11 
Conclusion
To date VCE capsule disruption has not been a well-established risk factor. There are now only two documented cases of capsule disruption; both which occurred after capsule retention of approximately three years. 8 In both patients the etiology for prolonged retained VCE capsule was poor treatment compliance and loss of follow-up. Although neither patient was found to have intestinal perforation, both patients were known to have multicentric small bowel obstructions. Increased sites for small bowel obstructions likely places the patient at increased risk for vascular compromise and subsequent perforation compared to the population. Due to this risk we propose physicians include the ability for reliable patient follow-up if capsule retention occurs during the decision-making process for patients and early consideration for surgical or endoscopic intervention in patients with concern for non-compliance.
